Literature DB >> 16999951

HO-1 and VGEF gene expression in human arteries with advanced atherosclerosis.

Wael G Morsi1, Olfat G Shaker, Emad F Ismail, Hanan H Ahmed, Taher I El-Serafi, Fathy A Maklady, Mohamed T Abdel-Aziz, Mohammed F El-Asmar, Hussein M Atta.   

Abstract

OBJECTIVES: Both heme oxygenase-1 (HO-1) and vascular endothelial growth factor (VEGF) have been shown to be involved in the progression of atherosclerosis. The relationship between HO-1 and VEGF gene expression and their proteins in endothelial cells from human atherosclerotic arterial specimens was investigated. DESIGN AND METHODS: The study included seventeen human arterial specimens with early and six specimens with advanced atherosclerotic lesions. Ten specimens were obtained from healthy young adults undergoing arterial reconstruction for trauma and were considered as non-atherosclerotic control. HO-1 and VEGF expressions as well as HO activity and VEGF protein content were measured in isolated endothelial cells (ECs).
RESULTS: HO-1 expression and activity (5.3+/-2.1 nmol bilirubin/mg protein/h) were only present in ECs from advanced atherosclerotic lesions. VEGF expression was more strongly expressed in ECs from advanced lesion compared with early lesions and was absent in healthy arteries. VEGF protein (1.35+/-0.69 ng/mg) was only detected in advanced lesions. A significant positive correlation (r=0.9, p<0.01) exists between HO activity and VEGF protein content in ECs of advanced lesions.
CONCLUSIONS: This study demonstrated that HO-1 expression and activity in ECs are present only in advanced atherosclerosis whereas, VEGF expression is present in early as well as in advanced atherosclerosis and the degree of its expression increases with severity of atherosclerosis. This study suggests an association between HO activity and VEGF protein in human ECs from advanced atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16999951     DOI: 10.1016/j.clinbiochem.2006.08.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

Review 1.  Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities.

Authors:  Young-Myeong Kim; Hyun-Ock Pae; Jeong Euy Park; Yong Chul Lee; Je Moon Woo; Nam-Ho Kim; Yoon Kyung Choi; Bok-Soo Lee; So Ri Kim; Hun-Taeg Chung
Journal:  Antioxid Redox Signal       Date:  2010-10-26       Impact factor: 8.401

Review 2.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

3.  The impact of vascular endothelial growth factor +405 C/G polymorphism on long-term outcome and severity of coronary artery disease.

Authors:  Samira Kalayi Nia; Shayan Ziaee; Mohammad Ali Boroumand; Maryam Sotudeh Anvari; Leyla Pourgholi; Arash Jalali
Journal:  J Clin Lab Anal       Date:  2016-10-05       Impact factor: 2.352

4.  Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.

Authors:  Wolfgang Lieb; Radwan Safa; Emelia J Benjamin; Vanessa Xanthakis; Xiaoyan Yin; Lisa M Sullivan; Martin G Larson; Holly M Smith; Joseph A Vita; Gary F Mitchell; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2009-02-17       Impact factor: 29.983

5.  Higher level of heme oxygenase-1 in patients with stroke than TIA.

Authors:  Xin Li; Guangfu Song; Yuling Jin; Hongwei Liu; Changqing Li; Chengwu Han; Shiyan Ren
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

6.  Keloid scarring, but not Dupuytren's contracture, is associated with unexplained carotid atherosclerosis.

Authors:  Sankalp Bhavsar; Andre Nimigan; Daniel G Hackam; David B O'Gorman; Bing Siang Gan; J David Spence
Journal:  Clin Invest Med       Date:  2009-04-01       Impact factor: 0.825

7.  Vaspin gene in rat adipose tissue: relation to obesity-induced insulin resistance.

Authors:  Olfat G Shaker; Nermin Abdel Hamid Sadik
Journal:  Mol Cell Biochem       Date:  2012-11-08       Impact factor: 3.396

8.  Zinc oxide nanoparticle-induced atherosclerotic alterations in vitro and in vivo.

Authors:  Zhen Yan; Wenjun Wang; Yongjun Wu; Wei Wang; Bing Li; Ning Liang; Weidong Wu
Journal:  Int J Nanomedicine       Date:  2017-06-13

9.  Molecular biomarkers of vascular dysfunction in obstructive sleep apnea.

Authors:  Elzbieta Kaczmarek; Jessie P Bakker; Douglas N Clarke; Eva Csizmadia; Olivier Kocher; Aristidis Veves; Francesco Tecilazich; Christopher P O'Donnell; Christiane Ferran; Atul Malhotra
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

Review 10.  Heme Oxygenase-1: Clinical Relevance in Ischemic Stroke.

Authors:  Daniel Bereczki; Jozsef Balla; Daniel Bereczki
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.